HCRN investigators Wellons, Kestle, Holubkov, Riva Cambrin and Limbrick recently met with the Clinical Trials group at NINDS (NIH). The purpose of the meeting was to discuss plans for a randomized trial on the management of hydrocephalus in premature infants with intraventricular hemorrhage. The PI for the trial will be Dr Jay Wellons, from the Birmingham Alabama center. The HCRN team discussed the study plan with the staff at NINDS and received feedback and suggestions.
The meeting was great exposure for HCRN at the NIH and helped them refine the study plan. The goal is to apply for NIH funding for the trial later this year
